Ignite Creation Date:
2024-05-06 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 2:27 PM
Study NCT ID:
NCT05284539
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2022-01-22
Brief Title:
Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFRALKROS1 Mutant Lung Cancer
Sponsor:
Organization:
Hunan Province Tumor Hospital
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
No
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
Samples With DNA
Bio Spec Description:
tissue sample and plasma DNA
Enrollment Count:
760
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 83957 |
Who Masked List: